SHANGHAI YIZHONG(SH:688091) Zheng Quan Zhi Xing·2025-05-29 12:12Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm confirms that the 2024 annual general meeting of Shanghai Yizhong Pharmaceutical Co., Ltd. was convened and conducted in accordance with relevant laws and regulations, ensuring the legality and validity of the meeting and its resolutions [1][5][10]. Group 1: Meeting Procedures - The notice for the 2024 annual general meeting was issued on May 29, 2025, detailing the meeting's convenor, date, time, and voting procedures [3][4]. - The meeting was held on May 29, 2025, at 14:00, combining both on-site and online voting methods [3][4]. - The meeting adhered to the procedures outlined in the Company Law and the Rules for General Meetings of Listed Companies, confirming the legality of the convening and conducting of the meeting [5][10]. Group 2: Attendance and Voting - A total of 68 shareholders and their proxies attended the meeting, representing 101,782,296 voting shares, which accounted for 49.2406% of the total shares [5][6]. - The online voting system recorded participation from 55 shareholders, representing 23,575,983 shares, or 11.4056% of the total shares [6]. - The qualifications of all attendees, including shareholders and proxies, were verified and deemed valid [6][10]. Group 3: Resolutions and Voting Results - The meeting approved the 2024 annual report and summary, with 101,611,261 votes in favor, representing 99.8319% of the valid votes [7][8]. - Other resolutions, including the independent director's work report, received similar overwhelming support, with approval rates consistently above 99% [8][9]. - The voting results were compiled from both on-site and online votes, confirming the legitimacy of the resolutions passed during the meeting [10].